AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 264 filers reported holding AVANOS MED INC in Q4 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $321,389 | -6.5% | 16,134 | -6.5% | 0.00% | 0.0% |
| Q1 2024 | $343,667 | -53.3% | 17,261 | -47.4% | 0.00% | -50.0% |
| Q4 2023 | $735,480 | -33.1% | 32,790 | -39.7% | 0.00% | -42.9% |
| Q3 2023 | $1,099,442 | -13.7% | 54,374 | +9.1% | 0.01% | -12.5% |
| Q2 2023 | $1,274,370 | -23.8% | 49,858 | -11.3% | 0.01% | -20.0% |
| Q1 2023 | $1,672,548 | +13.9% | 56,239 | +3.6% | 0.01% | +25.0% |
| Q4 2022 | $1,468,411 | -7.5% | 54,265 | -25.6% | 0.01% | 0.0% |
| Q3 2022 | $1,588,000 | -21.7% | 72,903 | -1.8% | 0.01% | -11.1% |
| Q2 2022 | $2,029,000 | -10.4% | 74,209 | +9.8% | 0.01% | 0.0% |
| Q1 2022 | $2,264,000 | +23.3% | 67,569 | +27.6% | 0.01% | -18.2% |
| Q4 2021 | $1,836,000 | +24.6% | 52,951 | +12.1% | 0.01% | +37.5% |
| Q3 2021 | $1,473,000 | -18.4% | 47,216 | -4.9% | 0.01% | -33.3% |
| Q2 2021 | $1,805,000 | – | 49,638 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,441,913 | $88,812,000 | 4.12% |
| RGM Capital, LLC | 2,157,612 | $78,472,000 | 3.63% |
| Millrace Asset Group, Inc. | 32,253 | $1,173,000 | 0.61% |
| HEARTLAND ADVISORS INC | 240,724 | $8,755,000 | 0.51% |
| Champlain Investment Partners, LLC | 2,607,033 | $94,818,000 | 0.45% |
| Campbell & CO Investment Adviser LLC | 27,200 | $989,000 | 0.41% |
| S.A. Mason LLC | 5,565 | $202,000 | 0.14% |
| XTX Topco Ltd | 8,240 | $300,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 15,186 | $552,000 | 0.10% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 16,875 | $614,000 | 0.09% |